|
1
|
Ernst C and Morton CC: Identification and
function of long non-coding RNA. Front Cell Neurosci. 7:1682013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ling H, Vincent K, Pichler M, Fodde R,
Berindan-Neagoe I, Slack FJ and Calin GA: Junk DNA and the long
non-coding RNA twist in cancer genetics. Oncogene. 34:5003–5011.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang CL: Cidofovir inhibits cervical
cancer cell Siha proliferation. Chin Gen M. 12:2012–1024. 2009.
|
|
7
|
Peterson EB, Ostroff JS, DuHamel KN,
DAgostino TA, Hernandez M, Canzona MR and Bylund CL: Impact of
provider-patient communication on cancer screening adherence: A
systematic review. Prev Med. 93:96–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
An JS, Huang MN, Song YM, Li N, Wu LY and
Zhan QM: A preliminary study of genes related to concomitant
chemoradiotherapy resistance in advanced uterine cervical squamous
cell carcinoma. Chin Med J (Engl). 126:4109–4115. 2013.PubMed/NCBI
|
|
9
|
Gadducci A, Tana R, Cosio S and Cionini L:
Treatment options in recurrent cervical cancer (Review). Oncol
Lett. 1:3–11. 2010.PubMed/NCBI
|
|
10
|
Wang GY, Zhu YY and Zhang YQ: The
functional role of long non-coding RNA in digestive system
carcinomas. Bull Cancer. 101:E27–E31. 2014.PubMed/NCBI
|
|
11
|
Maass PG, Luft FC and Bähring S: Long
non-coding RNA in health and disease. J Mol Med (Berl). 92:337–346.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Fu Z, Ji C, Gu P, Xu P, Yu N, Kan
Y, Wu X, Shen R and Shen Y: Systematic gene microarray analysis of
the lncRNA expression profiles in human uterine cervix carcinoma.
Biomed Pharmacother. 72:83–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang
SB, Jin ZJ, Sun SH, Wang F and Li W: Long noncoding RNA-EBIC
promotes tumor cell invasion by binding to EZH2 and repressing
E-cadherin in cervical cancer. PLoS One. 9:e1003402014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang F, Zhang L, Huo XS, Yuan JH, Xu D,
Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, et al: Long noncoding
RNA high expression in hepatocellular carcinoma facilitates tumor
growth through enhancer of zeste homolog 2 in humans. Hepatology.
54:1679–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang S, Zhang G and Liu J: Long noncoding
RNA PVT1 promotes cervical cancer progression through
epigenetically silencing miR-200b. APMIS. 124:649–658. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tseng YY, Moriarity BS, Gong W, Akiyama R,
Tiwari A, Kawakami H, Ronning P, Reuland B, Guenther K, Beadnell
TC, et al: PVT1 dependence in cancer with MYC copy-number increase.
Nature. 512:82–86. 2014.PubMed/NCBI
|
|
19
|
Yuan Y, Zhang J, Cai L, Ding C, Wang X,
Chen H, Wang X, Yan J and Lu J: Leptin induces cell proliferation
and reduces cell apoptosis by activating c-myc in cervical cancer.
Oncol Rep. 29:2291–2296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rughooputh S, Manraj S, Eddoo R and
Greenwell P: Expression of the c-myc oncogene and the presence of
HPV: 18: Possible surrogate markers for cervical cancer? Br J
Biomed Sci. 66:74–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liao LM, Sun XY, Liu AW, Wu JB, Cheng XL,
Lin JX, Zheng M and Huang L: Low expression of long noncoding
XLOC_010588 indicates a poor prognosis and promotes proliferation
through upregulation of c-Myc in cervical cancer. Gynecol Oncol.
133:616–623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Q, Guo X, Que S, Yang X, Fan H, Liu M,
Li X and Tang H: LncRNA RSU1P2 contributes to tumorigenesis by
acting as a ceRNA against let-7a in cervical cancer cells.
Oncotarget. Jul 26–2016.(Epub ahead of print). doi:
10.18632/oncotarget.10844.
|
|
24
|
Iden M, Fye S, Li K, Chowdhury T,
Ramchandran R and Rader JS: The lncRNA PVT1 contributes to the
cervical cancer phenotype and associates with poor patient
prognosis. PLoS One. 11:e01562742016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun R, Qin C, Jiang B, Fang S, Pan X, Peng
L, Liu Z, Li W, Li Y and Li G: Down-regulation of MALAT1 inhibits
cervical cancer cell invasion and metastasis by inhibition of
epithelial-mesenchymal transition. Mol Biosyst. 12:952–962. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yan B, Yao J, Liu JY, Li XM, Wang XQ, Li
YJ, Tao ZF, Song YC, Chen Q and Jiang Q: lncRNA-MIAT regulates
microvascular dysfunction by functioning as a competing endogenous
RNA. Circ Res. 116:1143–1156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Yao T, Wang Y, Yu J, Liu Y and
Lin Z: Long noncoding RNA MEG3 is downregulated in cervical cancer
and affects cell proliferation and apoptosis by regulating miR-21.
Cancer Biol Ther. 17:104–113. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu H, He Y, Lin L, Qi Z, Ma L, Li L and Su
Y: Long non-coding RNA MALAT1 modulates radiosensitivity of
HR-HPV+ cervical cancer via sponging miR-145. Tumour
Biol. 37:1683–1691. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu S, Song L, Yao H, Zhang L, Xu D, Gao F
and Li Q: MiR-375 is epigenetically downregulated by HPV-16 E6
mediated DNMT1 upregulation and modulates EMT of cervical cancer
cells by suppressing lncRNA MALAT1. PLoS One. 11:e01634602016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou
WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation
of the MiR-200 family contributes to H19-mediated metastasis
suppression in hepatocellular carcinoma. Carcinogenesis.
34:577–586. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao H, Peng R, Liu Q, Liu D, Du P, Yuan
J, Peng G and Liao Y: The lncRNA H19 interacts with miR-140 to
modulate glioma growth by targeting iASPP. Arch Biochem Biophys.
610:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huang M, Zhong Z, Lv M, Shu J, Tian Q and
Chen J: Comprehensive analysis of differentially expressed profiles
of lncRNAs and circRNAs with associated co-expression and ceRNA
networks in bladder carcinoma. Oncotarget. 7:47186–47200. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bosch FX, Manos MM, Muñoz N, Sherman M,
Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R and Shah KV:
Prevalence of human papillomavirus in cervical cancer: A worldwide
perspective. International biological study on cervical cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Greco D, Kivi N, Qian K, Leivonen SK,
Auvinen P and Auvinen E: Human papillomavirus 16 E5 modulates the
expression of host microRNAs. PLoS One. 6:e216462011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sasagawa T, Takagi H and Makinoda S:
Immune responses against human papillomavirus (HPV) infection and
evasion of host defense in cervical cancer. J Infect Chemother.
18:807–815. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Khorasanizadeh F, Hassanloo J, Khaksar N,
Taheri Mohammad S, Marzaban M, Rashidi HB, Sari Akbari A and
Zendehdel K: Epidemiology of cervical cancer and human papilloma
virus infection among Iranian women - analyses of national data and
systematic review of the literature. Gynecol Oncol. 128:277–281.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sharma S, Mandal P, Sadhukhan T, Chowdhury
Roy R, Ranjan Mondal N, Chakravarty B, Chatterjee T, Roy S and
Sengupta S: Bridging links between long noncoding RNA HOTAIR and
HPV oncoprotein e7 in cervical cancer pathogenesis. Sci Rep.
5:117242015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Leung CO, Deng W, Ye TM, Ngan HY, Tsao SW,
Cheung AN, Pang RT and Yeung WS: miR-135a leads to cervical cancer
cell transformation through regulation of β-catenin via a
SIAH1-dependent ubiquitin proteosomal pathway. Carcinogenesis.
35:1931–1940. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et
al: Functional demarcation of active and silent chromatin domains
in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim HJ, Lee DW, Yim GW, Nam EJ, Kim S, Kim
SW and Kim YT: Long non-coding RNA HOTAIR is associated with human
cervical cancer progression. Int J Oncol. 46:521–530. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang L, Liao LM, Liu AW, Wu JB, Cheng XL,
Lin JX and Zheng M: Overexpression of long noncoding RNA HOTAIR
predicts a poor prognosis in patients with cervical cancer. Arch
Gynecol Obstet. 290:717–723. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Guo L, Lu X, Zheng L, Liu X and Hu M:
Association of long non-coding RNA HOTAIR polymorphisms with
cervical cancer risk in a chinese population. PLoS One.
11:e01600392016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sharma Sweta S, Roy Rahul C and Ranjan
Nidhu M: Identification of genetic variation in the lncRNA HOTAIR
associated with HPV16-related cervical cancer pathogenesis. Cell
Oncol. 9:282016.
|
|
50
|
Guertin DA and Sabatini DM: Defining the
role of mTOR in cancer. Cancer Cell. 12:9–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang D, Zhou XH, Zhang J, Zhou YX, Ying
J, Wu GQ and Qian JH: Propofol promotes cell apoptosis via
inhibiting HOTAIR mediated mTOR pathway in cervical cancer. Biochem
Biophys Res Commun. 468:561–567. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee M, Kim HJ, Kim SW, Park SA, Chun KH,
Cho NH, Song YS and Kim YT: The long non-coding RNA HOTAIR
increases tumour growth and invasion in cervical cancer by
targeting the Notch pathway. Oncotarget. 7:44558–44571. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jing L, Yuan W, Ruofan D, Jinjin Y and
Haifeng Q: HOTAIR enhanced aggressive biological behaviors and
induced radio-resistance via inhibiting p21 in cervical cancer.
Tumour Biol. 36:3611–3619. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Li L, Liu B, Wapinski OL, Tsai MC, Qu K,
Zhang J, Carlson JC, Lin M, Fang F, Gupta RA, et al: Targeted
disruption of Hotair leads to homeotic transformation and gene
derepression. Cell Rep. 5:3–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ding C, Cheng S, Yang Z, Lv Z, Xiao H, Du
C, Peng C, Xie H, Zhou L, Wu J, et al: Long non-coding RNA HOTAIR
promotes cell migration and invasion via down-regulation of RNA
binding motif protein 38 in hepatocellular carcinoma cells. Int J
Mol Sci. 15:4060–4076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J
and Liu M: Long intergenic noncoding RNA HOTAIR is overexpressed
and regulates PTEN methylation in laryngeal squamous cell
carcinoma. Am J Pathol. 182:64–70. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Carrion K, Dyo J, Patel V, Sasik R,
Mohamed SA, Hardiman G and Nigam V: The long non-coding
HOTAIR is modulated by cyclic stretch and WNT/β-CATENIN in
human aortic valve cells and is a novel repressor of calcification
genes. PLoS One. 9:e965772014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lee DF, Su J, Kim HS, Chang B, Papatsenko
D, Zhao R, Yuan Y, Gingold J, Xia W, Darr H, et al: Modeling
familial cancer with induced pluripotent stem cells. Cell.
161:240–254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yoshimizu T, Miroglio A, Ripoche MA,
Gabory A, Vernucci M, Riccio A, Colnot S, Godard C, Terris B,
Jammes H, et al: The H19 locus acts in vivo as a tumor suppressor.
Proc Natl Acad Sci USA. 105:12417–12422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim
JM and Oh YK: Alterations in promoter usage and expression levels
of insulin-like growth factor-II and H19 genes in cervical
carcinoma exhibiting biallelic expression of IGF-II. Biochim
Biophys Acta. 1586:307–315. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Yang L, Bai HS, Deng Y and Fan L: High
MALAT1 expression predicts a poor prognosis of cervical cancer and
promotes cancer cell growth and invasion. Eur Rev Med Pharmacol
Sci. 19:3187–3193. 2015.PubMed/NCBI
|
|
66
|
Redis RS, Sieuwerts AM, Look MP, Tudoran
O, Ivan C, Spizzo R, Zhang X, de Weerd V, Shimizu M, Ling H, et al:
CCAT2, a novel long non-coding RNA in breast cancer: Expression
study and clinical correlations. Oncotarget. 4:1748–1762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wu L, Jin L, Zhang W and Zhang L: Roles of
long non-coding RNA CCAT2 in cervical cancer cell growth and
apoptosis. Med Sci Monit. 22:875–879. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Chen X, Liu L and Zhu W: Up-regulation of
long non-coding RNA CCAT2 correlates with tumor metastasis and poor
prognosis in cervical squamous cell cancer patients. Int J Clin Exp
Pathol. 8:13261–13266. 2015.PubMed/NCBI
|
|
69
|
Khaitan D, Dinger ME, Mazar J, Crawford J,
Smith MA, Mattick JS and Perera RJ: The melanoma-upregulated long
noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer
Res. 71:3852–3862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Liu T, Shen SK, Xiong JG, Xu Y, Zhang HQ,
Liu HJ and Lu ZG: Clinical significance of long noncoding RNA
SPRY4-IT1 in melanoma patients. FEBS Open Bio. 6:147–154. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Xie M, Nie FQ, Sun M, Xia R, Liu YW, Zhou
P, De W and Liu XH: Decreased long noncoding RNA SPRY4-IT1
contributing to gastric cancer cell metastasis partly via affecting
epithelial-mesenchymal transition. J Transl Med. 13:2502015.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong
R, Yang JS, Xu TP, Liu YW, Zou YF, et al: EZH2-mediated epigenetic
suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell
proliferation and metastasis by affecting the
epithelial-mesenchymal transition. Cell Death Dis. 5:e12982014.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Xie HW, Wu QQ, Zhu B, Chen FJ, Ji L, Li
SQ, Wang CM, Tong YS, Tuo L, Wu M, et al: Long noncoding RNA
SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and
associated with poor prognosis. Tumour Biol. 35:7743–7754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Peng W, Wu G, Fan H, Wu J and Feng J: Long
noncoding RNA SPRY4-IT1 predicts poor patient prognosis and
promotes tumorigenesis in gastric cancer. Tumour Biol.
36:6751–6758. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Zhao XL, Zhao ZH, Xu WC, Hou JQ and Du XY:
Increased expression of SPRY4-IT1 predicts poor prognosis and
promotes tumor growth and metastasis in bladder cancer. Int J Clin
Exp Pathol. 8:1954–1960. 2015.PubMed/NCBI
|
|
76
|
Zhang HM, Yang FQ, Yan Y, Che JP and Zheng
JH: High expression of long non-coding RNA SPRY4-IT1 predicts poor
prognosis of clear cell renal cell carcinoma. Int J Clin Exp
Pathol. 7:5801–5809. 2014.PubMed/NCBI
|
|
77
|
Cao Y, Liu Y, Lu X, Wang Y, Qiao H and Liu
M: Upregulation of long noncoding RNA SPRY4-IT1 correlates with
tumor progression and poor prognosis in cervical cancer. FEBS Open
Bio. 6:954–960. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wu Y, Lyu H, Liu H, Shi X, Song Y and Liu
B: Downregulation of the long noncoding RNA GAS5-AS1 contributes to
tumor metastasis in non-small cell lung cancer. Sci Rep.
6:310932016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liang W, Lv T, Shi X, Liu H, Zhu Q, Zeng
J, Yang W, Yin J and Song Y: Circulating long noncoding RNA GAS5 is
a novel biomarker for the diagnosis of nonsmall cell lung cancer.
Medicine (Baltimore). 95:e46082016. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang N, Wang AY, Wang XK, Sun XM and Xue
HZ: GAS5 is downregulated in gastric cancer cells by promoter
hypermethylation and regulates adriamycin sensitivity. Eur Rev Med
Pharmacol Sci. 20:3199–3205. 2016.PubMed/NCBI
|
|
81
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783.
2014.PubMed/NCBI
|
|
82
|
Peng W and Fan H: Long noncoding RNA CCHE1
indicates a poor prognosis of hepatocellular carcinoma and promotes
carcinogenesis via activation of the ERK/MAPK pathway. Biomed
Pharmacother. 83:450–455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Han J, Zhou W, Jia M, Wen J, Jiang J, Shi
J, Zhang K, Ma H, Liu J, Ren J, et al: Expression quantitative
trait loci in long non-coding RNA PAX8-AS1 are associated with
decreased risk of cervical cancer. Mol Genet Genomics.
291:1743–1748. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Tacha D, Zhou D and Cheng L: Expression of
PAX8 in normal and neoplastic tissues: A comprehensive
immunohistochemical study. Appl Immunohistochem Mol Morphol.
19:293–299. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Waters L, Crumley S, Truong L, Mody D and
Coffey D: PAX2 and PAX8: Useful markers for metastatic effusions.
Acta Cytol. 58:60–66. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhang X, Gejman R, Mahta A, Zhong Y, Rice
KA, Zhou Y, Cheunsuchon P, Louis DN and Klibanski A: Maternally
expressed gene 3, an imprinted noncoding RNA gene, is associated
with meningioma pathogenesis and progression. Cancer Res.
70:2350–2358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Qin R, Chen Z, Ding Y, Hao J, Hu J and Guo
F: Long non-coding RNA MEG3 inhibits the proliferation of cervical
carcinoma cells through the induction of cell cycle arrest and
apoptosis. Neoplasma. 60:486–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Jiang S, Wang HL and Yang J: Low
expression of long non-coding RNA LET inhibits carcinogenesis of
cervical cancer. Int J Clin Exp Pathol. 8:806–811. 2015.PubMed/NCBI
|
|
91
|
Khalil AM, Guttman M, Huarte M, Garber M,
Raj A, Morales Rivea D, Thomas K, Presser A, Bernstein BE, van
Oudenaarden A, et al: Many human large intergenic noncoding RNAs
associate with chromatin-modifying complexes and affect gene
expression. Proc Natl Acad Sci USA. 106:11667–11672. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Guan Y, Kuo WL, Stilwell JL, Takano H,
Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, et al:
Amplification of PVT1 contributes to the pathophysiology of ovarian
and breast cancer. Clin Cancer Res. 13:5745–5755. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Barsotti AM1, Beckerman R, Laptenko O,
Huppi K, Caplen NJ and Prives C: P53-dependent induction of PVT1
and miR-1204. J Biol Chem. 287:2509–2519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Paci P, Colombo T and Farina L:
Computational analysis identifies a sponge interaction network
between long non-coding RNAs and messenger RNAs in human breast
cancer. BMC Syst Biol. 8:832014. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Kong R, Zhang EB, Yin DD, You LH, Xu TP,
Chen WM, Xia R, Wan L, Sun M, Wang ZX, et al: Long noncoding RNA
PVT1 indicates a poor prognosis of gastric cancer and promotes cell
proliferation through epigenetically regulating p15 and p16. Mol
Cancer. 14:822015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu
QH, Weng WW, Tan C, Sheng WQ, Zhou XY, et al: Circulating CUDR,
LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish
patients with gastric cancer from healthy controls. Int J Cancer.
137:1128–1135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Ronnau CG, Verhaegh GW, Luna-Velez MV and
Schalken JA: Noncoding RNAs as novel biomarkers in prostate cancer.
BioMed Res Int. 2014:5917032014.https://doi.org/10.1155/2014/591703 View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Isin M, Ozgur E, Cetin G, Erten N, Aktan
M, Gezer U and Dalay N: Investigation of circulating lncRNAs in
B-cell neoplasms. Clin Chim Acta. 431:255–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Lorenzen JM, Schauerte C, Kielstein JT,
Hübner A, Martino F, Fiedler J, Gupta SK, Faulhaber-Walter R,
Kumarswamy R, Hafer C, et al: Circulating long noncoding RNATapSaki
is a predictor of mortality in critically ill patients with acute
kidney injury. Clin Chem. 61:191–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Dong L, Lin W, Qi P, Xu MD, Wu X, Ni S,
Huang D, Weng WW, Tan C, Sheng W, et al: Circulating long RNAs in
serum extracellular vesicles: Their characterization and potential
application as biomarkers for diagnosis of colorectal cancer.
Cancer Epidemiol Biomarkers Prev. 25:1158–1166. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Wang F, Ren S, Chen R, Lu J, Shi X, Zhu Y,
Zhang W, Jing T, Zhang C, Shen J, et al: Development and
prospective multicenter evaluation of the long noncoding RNA
MALAT-1 as a diagnostic urinary biomarker for prostate cancer.
Oncotarget. 5:11091–11102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Crea F, Watahiki A, Quagliata L, Xue H,
Pikor L, Parolia A, Wang Y, Lin D, Lam WL, Farrar WL, et al:
Identification of a long non-coding RNA as a novel biomarker and
potential therapeutic target for metastatic prostate cancer.
Oncotarget. 5:764–774. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Merola R, Tomao L, Antenucci A, Sperduti
I, Sentinelli S, Masi S, Mandoj C, Orlandi G, Papalia R,
Guaglianone S, et al: PCA3 in prostate cancer and tumor
aggressiveness detection on 407 high-risk patients: A National
Cancer Institute experience. J Exp Clin Cancer Res. 34:152015.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Arita T, Ichikawa D, Konishi H, Komatsu S,
Shiozaki A, Shoda K, Kawaguchi T, Hirajima S, Nagata H, Kubota T,
et al: Circulating long non-coding RNAs in plasma of patients with
gastric cancer. Anticancer Res. 33:3185–3193. 2013.PubMed/NCBI
|
|
105
|
Zhou X, Yin C, Dang Y, Ye F and Zhang G:
Identification of the long non-coding RNA H19 in plasma as a novel
biomarker for diagnosis of gastric cancer. Sci Rep. 5:115162015.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Xie H, Ma H and Zhou D: Plasma HULC as a
promising novel biomarker for the detection of hepatocellular
carcinoma. BioMed Res Int. 2013:1361062013.https://doi.org/10.1155/2013/136106 View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Lu J, Xie F, Geng L, Shen W, Sui C and
Yang J: Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935
expression profile in patients with hepatocellular carcinoma and
HBV. Tumour Biol. 36:3231–3236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Tang J, Jiang R, Deng L, Zhang X, Wang K
and Sun B: Circulation long non-coding RNAs act as biomarkers for
predicting tumorigenesis and metastasis in hepatocellular
carcinoma. Oncotarget. 6:4505–4515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Li J, Wang X, Tang J, Jiang R, Zhang W, Ji
J and Sun B: HULC and Linc00152 act as novel biomarkers in
predicting diagnosis of hepatocellular carcinoma. Cell Physiol
Biochem. 37:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Li J, Wang Y, Yu J, Dong R and Qiu H: A
high level of circulating HOTAIR is associated with progression and
poor prognosis of cervical cancer. Tumour Biol. 36:1661–1665. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Ahadi A, Brennan S, Kennedy PJ, Hutvagner
G and Tran N: Long non-coding RNAs harboring miRNA seed regions are
enriched in prostate cancer exosomes. Sci Rep. 6:249222016.
View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Berrondo C, Flax J, Kucherov V, Siebert A,
Osinski T, Rosenberg A, Fucile C, Richheimer S and Beckham CJ:
Expression of the long non-coding RNA HOTAIR correlates with
disease progression in bladder cancer and is contained in bladder
cancer patient urinary exosomes. PLoS One. 11:e01472362016.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Wang J, Zhou Y, Lu J, Sun Y, Xiao H, Liu M
and Tian L: Combined detection of serum exosomal miR-21 and HOTAIR
as diagnostic and prognostic biomarkers for laryngeal squamous cell
carcinoma. Med Oncol. 31:1482014. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Zhang J, Liu SC, Luo XH, Tao GX, Guan M,
Yuan H and Hu DK: Exosomal long noncoding RNAs are differentially
expressed in the cervicovaginal lavage samples of cervical cancer
patients. J Clin Lab Anal. 30:1116–1121. 2016. View Article : Google Scholar : PubMed/NCBI
|
